Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Double Helix Optics is a leader in 3D nano-scale imaging and sensing, providing solutions that overcome the limitations of traditional 2D microscopy. The company's proprietary Light Engineering technology utilizes Point Spread Function (PSF) engineering to enable high-precision 3D capture of objects ranging from single molecules to whole cells. Their flagship product, the SPINDLE module, integrates with existing microscopes to provide super-resolution and extended depth of field capabilities. Double Helix Optics serves the life sciences, drug discovery, and material science markets by offering both hardware and advanced 3D reconstruction software. The company is headquartered in Boulder, Colorado, and was founded based on research from the University of Colorado Boulder. Their technology is used by researchers globally to visualize complex biological processes in three dimensions with unprecedented detail.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Double Helix Optics.